Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $21.9 Million - $24 Million
152,000 New
152,000 $22.2 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $1.02 Million - $1.11 Million
7,000 New
7,000 $1.1 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $19.1 Million - $22.8 Million
-126,300 Reduced 88.69%
16,100 $2.5 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $2.9 Million - $3.25 Million
-18,100 Reduced 11.28%
142,400 $24.9 Million
Q3 2022

Nov 15, 2022

BUY
$161.33 - $179.52 $1.26 Million - $1.4 Million
7,800 Added 5.11%
160,500 $26.4 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $25.2 Million - $27.9 Million
150,000 Added 5555.56%
152,700 $27 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $33.4 Million - $37 Million
-213,900 Reduced 98.75%
2,700 $458,000
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $29.7 Million - $34.1 Million
216,600 New
216,600 $33.7 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $43.2 Million - $59.9 Million
-388,700 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $24.3 Million - $27.9 Million
190,300 Added 95.92%
388,700 $55.7 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $19.9 Million - $23.4 Million
164,000 Added 476.74%
198,400 $27.8 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $26.6 Million - $29.3 Million
-222,600 Reduced 86.61%
34,400 $3.19 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $33.7 Million - $36.9 Million
257,000
257,000 $35.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.